by Katie Dineen, Preclinical Business Development Manager @ MLM Medical Labs Welcome to the realm of preclinical study design, where every choice holds the key to scientific triumph! In this blog post, we’ll dive into the world of best practices, unlocking the secrets to effective preclinical studies. Join us as we explore how MLM Medical […]
We are thrilled to announce the launch of our newly optimized IPF (Idiopathic Pulmonary Fibrosis) preclinical disease model. This model release is positioned to expand research opportunities in the fight against lung disease, providing researchers with an advanced tool to unlock new insights and accelerate the quest for effective treatments. Most remarkable about this optimization
We are extremely excited to announce the successful validation of the MC903 Atopic Dermatitis Model. This preclinical model, the 62nd in MLM’s growing lineup of validated models, provides an ideal solution for companies involved in translational and preclinical research in the field of atopic dermatitis. Atopic dermatitis, a prevalent chronic inflammatory skin condition, presents significant
Cutting-Edge, High Throughput Technology Enhances and Accelerates Research Capabilities: MLM Medical Laboratories Acquires Leica Biosystems Aperio GT-450 Scanner We are pleased to announce a very significant expansion of our already robust Histology capabilities with the recent acquisition of the state-of-the-art Leica Biosystems Aperio GT-450 Scanner. This cutting-edge digital pathology solution will revolutionize MLM’s capabilities in
MLM Medical Labs Supports Leading Biotech Company in a Non-Interventional Hidradenitis Suppurativa (HS) Study MLM Medical Labs – Minneapolis recently partnered with a leading biotech company on the CSL324 study of a novel, fully human anti-G-CSF receptor (G-CSFR) monoclonal antibody in the treatment of hidradenitis suppurativa (HS). CSL324 is being investigated as a potential treatment in
MLM Participates in Important Non-Inverventional Hidradenitis Suppurativa (HS) Study Read More »
Pipelines are full, but progress and efficiencies are low! Central Labs are often part of the problem, when they could and should be a crucial part of the solution!
Let’s talk central labs @DIA US 2023! Read More »
Pipelines are full, but progress and efficiencies are low! Central Labs are often part of the problem, when they could and should be a crucial part of the solution!
Let’s talk central labs @BIO 2023! Read More »
MLM Medical Labs – Memphis Receives Accreditation from the College of American Pathologists We are thrilled to announce today receipt of accreditation from the College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists and a leading provider of laboratory accreditation programs, for our laboratory facilities in Memphis, TN. MLM Medical Labs –
MLM Memphis Receives CAP Accreditation Read More »
Is your Lab an issue or limitation on any level in your clinical trial? Let’s meet at OCT West Coast. Booth #23 is your chance to move past these sticky wickets!
It’s Time to Meet | OCT West Coast Read More »
Let your Central Lab be part of the Solution, never part of the problem. Meet us at Booth #6 @ COG UK.
Let’s Chat at COG UK ! Read More »
